“Car-T and Bispecific Antibodies for Refractory Non-Hodgkin Lymphoma: Long-Term Safety and Autoimmune Sequelae”. 2025. Journal of Carcinogenesis 24 (6s): 805-20. https://doi.org/10.64149/J.Carcinog.24.6s.805-820.